Streetbeat News

Stock Prices

BDRX

Biodexa Pharmaceuticals announced positive Phase 2 trial results for eRapa in treating Familial Adenomatous Polyposis, showing significant non-progression and reduction in polyp burden. These results will inform Phase 3 dosage. The findings were presented at the 2024 InSIGHT meeting.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:32 pm

BFRI

Biofrontera Inc. (NASDAQ:BFRI) has launched its FDA-approved RhodoLED XL lamp, designed for use with Ameluz® gel in photodynamic therapy for actinic keratoses. The company began commercial distribution on June 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:31 pm

JVA

Coffee Holding has terminated its merger agreement with Delta Corp. Holdings. This decision may impact Coffee Holding's stock in the short term.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:31 pm

LLY

Eli Lilly's tirzepatide injection, marketed as Zepbound in the U.S., has shown significant efficacy in treating moderate-to-severe obstructive sleep apnea (OSA) in obese patients, achieving primary and key secondary endpoints in phase 3 trials. The company has submitted tirzepatide for FDA approval for this indication, with a decision expected by the end of the year.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 12:29 pm

DOMO

PBF

TALO

Insiders have made significant purchases in Domo, PBF Energy, and Talos Energy, indicating confidence in these companies' prospects. Notable trades include $2.72M in Domo, $24.7M in PBF Energy, and $3.24M in Talos Energy.

Portfolio Pulse from Avi Kapoor

June 24, 2024 | 12:25 pm

EDSA

Edesa Biotech shares are trading higher after BARDA selected the company's drug for a U.S. funded platform trial in general acute respiratory distress syndrome.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:24 pm

AMWD

ATKR

CXW

The article highlights three industrial stocks that are currently oversold and may present buying opportunities: American Woodmark Corporation (AMWD), Atkore Inc (ATKR), and Corecivic Inc (CXW). These stocks have RSI values below 30, indicating potential undervaluation.

Portfolio Pulse from Avi Kapoor

June 24, 2024 | 12:21 pm

NVDA

Nvidia shares are trading lower, potentially pulling back after recent momentum.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:18 pm

APIE

DFIV

HSBC

ABN Amro is nearing a deal to buy HSBC's German wealth management unit, extending its expansion into Germany. The transaction follows ABN Amro's recent purchase of Hauck Aufhaeuser Lampe. HSBC aims to overhaul its German operations. HSBC shares have gained 14% in the last 12 months.

Portfolio Pulse from Lekha Gupta

June 24, 2024 | 12:17 pm

RELI

Reliance Global Group has withdrawn its registration statement with the SEC, eliminating the perceived warrant overhang and simplifying its capital structure. The company is optimistic about its future, including a planned acquisition of Spetner Associates, which is expected to significantly boost revenues and cash flows.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:16 pm